LuKLooTLBenvenutoJABenjaminRSValdiviesoMFreireichEJ. Pharmacological disposition and metabolism of ftorafur. Pharmacology1975; 17: 202–9.
2.
DiasoRBHunterHLLabuddeJAMayolRF. Pharmacologic study of oral ftorafur: Potential for improved oral delivery of 5-fluorouracil. Proc Am Assoc Cancer Res ASCO1979; 20: 401–11.
3.
BlokhinaNJVoznyEKGariAM. Results of treatment of malignant tumors with ftorafur. Cancer1972; 30: 390–7.
4.
ValdiviesoMBodeyGPGottliebJAFreireichEJ. Clinical evaluation of ftorafur (pyrimidine-deoxyribose N1–2′-furanidyl-5-fluorouracil. Cancer Res1976; 36: 1821–8.
5.
FriedmanMAIgnoffoRJ. A review of the United States clinical experience of the fluoropyrimidine, ftorafur (NSC-148958). Cancer Treat Rev1980; 7: 205–11.
6.
BedikianAYBodeyGPValdiviesoMBurgessMA. Phase 1 evaluation of oral tegafur. Cancer Treat Rev1983; 67: 81–90.
